Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Sales | 5,026 | 5,561 | 47,839 | 4,070 | 5,660 |
Cost of Goods | 21,129 | 15,925 | 11,209 | 0 | 0 |
Gross Profit | -16,103 | -10,364 | 36,630 | 4,070 | 5,660 |
Operating Expenses | 24,050 | 28,017 | 35,069 | 32,942 | 40,028 |
Operating Income | -40,024 | -37,456 | 1,770 | -28,872 | -34,368 |
Interest Expense | 8,446 | 7,438 | 1,498 | 1,426 | 2,189 |
Other Income | 27,160 | 8,162 | -39,887 | 2,320 | -3,974 |
Pre-tax Income | -21,310 | -36,732 | -39,615 | -27,978 | -40,531 |
Net Income Continuous | -21,310 | -36,732 | -39,615 | -27,978 | -40,531 |
Net Income | $-21,310 | $-36,732 | $-39,615 | $-27,978 | $-40,531 |
EPS Basic Total Ops | -1.08 | -2.07 | -2.38 | -2.24 | -5.97 |
EPS Basic Continuous Ops | -1.08 | -2.07 | -2.38 | -2.24 | -5.97 |
EPS Diluted Total Ops | -1.08 | -2.07 | -2.38 | -2.24 | -5.97 |
EPS Diluted Continuous Ops | -1.08 | -2.07 | -2.38 | -2.24 | -5.97 |
EPS Diluted Before Non-Recurring Items | -2.46 | -2.53 | 0.02 | -2.24 | -5.40 |
EBITDA(a) | $-34,696 | $-31,684 | $6,172 | $-24,088 | $-29,130 |